• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Microbiol . Assessing the Mobility of Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Glycans by Structural and Computational M

tetano

Editor, Senior Moderator
Front Microbiol


. 2022 Apr 15;13:870938.
doi: 10.3389/fmicb.2022.870938. eCollection 2022.
Assessing the Mobility of Severe Acute Respiratory Syndrome Coronavirus-2 Spike Protein Glycans by Structural and Computational Methods


Soledad Stagnoli[SUP] 1 [/SUP], Francesca Peccati[SUP] 2 [/SUP], Sean R Connell[SUP] 1 3 4 [/SUP], Ane Martinez-Castillo[SUP] 1 [/SUP], Diego Charro[SUP] 1 [/SUP], Oscar Millet[SUP] 5 [/SUP], Chiara Bruzzone[SUP] 5 [/SUP], Asis Palazon[SUP] 3 6 [/SUP], Ana Ardá[SUP] 3 7 [/SUP], Jesús Jiménez-Barbero[SUP] 3 7 [/SUP], June Ereño-Orbea[SUP] 3 7 [/SUP], Nicola G A Abrescia[SUP] 1 3 8 [/SUP], Gonzalo Jiménez-Osés[SUP] 2 3 [/SUP]



Affiliations

Abstract

Two years after its emergence, the coronavirus disease-2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) remains difficult to control despite the availability of several vaccines. The extensively glycosylated SARS-CoV-2 spike (S) protein, which mediates host cell entry by binding to the angiotensin converting enzyme 2 (ACE2) through its receptor binding domain (RBD), is the major target of neutralizing antibodies. Like to many other viral fusion proteins, the SARS-CoV-2 spike protein utilizes a glycan shield to thwart the host immune response. To grasp the influence of chemical signatures on carbohydrate mobility and reconcile the cryo-EM density of specific glycans we combined our cryo-EM map of the S ectodomain to 4.1 Å resolution, reconstructed from a limited number of particles, and all-atom molecular dynamics simulations. Chemical modifications modeled on representative glycans (defucosylation, sialylation and addition of terminal LacNAc units) show no significant influence on either protein shielding or glycan flexibility. By estimating at selected sites the local correlation between the full density map and atomic model-based maps derived from molecular dynamics simulations, we provide insight into the geometries of the α-Man-(1→3)-[α-Man-(1→6)-]-β-Man-(1→4)-β-GlcNAc(1→4)-β-GlcNAc core common to all N-glycosylation sites.

Keywords: SARS-CoV-2; cryo-EM; glycans; molecular dynamics; spike.
 
Back
Top Bottom